Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients. Liu J, Ladbury C, Kim J, Raz D, et al. J Thorac Oncol 2022;17:194-196.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu J, Ladbury C, Kim J, Raz D, et al. Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients. J Thorac Oncol 2022;17:194-196.
PMID: 35074226